In 1983, Congress passed the Orphan Drug Act (“ODA”) as part of an effort to provide market incentives for pharmaceutical manufacturers to produce “orphan drugs,” drugs for diseases that impact less ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback